Drug Discovery

#Characterisation #Drug discovery #Mass spectrometry / NMR #Protein chemistry / Proteomics

Addressing the challenges in membrane protein characterisation

Dr Sofia Ferreira, Director of Applications at Refeyn, discusses how various technologies can address the main challenges in membrane protein characterisation, describing how novel technologies, such as mass photometry, can streamline and support analytical processes.  Dissecting the structure of membrane proteins  Membrane proteins play a crucial role… Read More

#Exclusive Content

Handshake jigsaw puzzle
#Cancer #Clinical trials #Drug development #Paediatrics

Advancing paediatric cancer research through partnerships 

Paediatric oncologist Gauri Sunkersett shares her unique background and research approach at AbbVie to help find answers for the youngest blood cancer patients.   When I was a second-year resident training as a paediatric oncologist at Nicklaus Children’s Hospital, I met a teenage boy diagnosed with Hodgkin’s… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Collaboration #Drug development #Drug discovery #Partnership

Key industry partnerships advancing drug discovery

Otsuka Pharmaceutical and Ionis Pharmaceuticals Otsuka Pharmaceutical and RNA therapy company Ionis have entered into a licence agreement for Otsuka to acquire exclusive marketing rights to Ionis’ hereditary angioedema (HAE) drug candidate donidalorsen in Europe. Donidalorsen is an investigational ligand-conjugated antisense (LICA) medicine designed to target the prekallikrein,… Read More

#Business & Investment #News

Human cell
#Biologics #Cell and gene therapy #Cytomos #Lab technology #Single-cell analysis

Can cell analysis tech help streamline biotech product development?

Scotland-based biotech Cytomos has launched its newly patented AuraCyt cell analysis technology brand. According to the company, AuraCyt provides information on cell properties and can be incorporated in-line, allowing real-time monitoring of cell manufacturing events and predicting manufacturing success. It is designed to collect data that… Read More

#Business & Investment #News

Neuroscience innovation
#AI #Alzheimer's #Artificial intelligence (AI) #Biomarkers #Brain disease #Drug discovery #Inherited tauopathies #Mental health #Nervous system disorders #Neurodegenerative disorders #Neurology #Neuroscience #Neurotechnology #Psychiatry #Tau protein

New podcast on innovation in neuroscience

This is the latest episode of the free DDW narrated podcast, titled “Where is the latest innovation in neuroscience?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Taking a new approach to tackle neurodegenerative diseases,… Read More

#News

#Drug discovery #iPSC #Neurology #Preclinical development #Preclinical investigations

Case Study: How to generate publishable data in just 12 weeks

A new resource is now available to download for free from sponsors Bit Bio: ‘Speeding up neuroscience research: Generating publishable data in 12 weeks‘. In this Case Study you will learn: How Professor Deepak Srivastava’s lab at King’s College London are working to unpick the complex… Read More

#News

#Drug discovery #iPSC #Neurology #Preclinical development #Preclinical investigations

Speeding up neuroscience research: Generating publishable data in 12 weeks

In this Case Study you will learn: How Professor Deepak Srivastava’s lab at King’s College London are working to unpick the complex biology of neuronal synapses to help us better understand neurological disorders like schizophrenia. How the researchers in Professor Srivastava’s lab have been able to generate publishable data… Read More

#Resources

Boston, MA
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Lab technology #SLAS2024

SLAS2024 Ignite Theater: Will you be there?

Make sure you leave time in your SLAS2024 schedule to attend the Ignite Theater track on the theme ‘Innovation & technology: from lab to patient’. The programme, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation, will feature leading research from… Read More

#News

Microplate
#Assay development optimisation & technology #Aurora Microplates #Drug discovery #Lab technology

Ensuring reliable assays: Why the ideal microplate is an invisible one

In a DDW Sitting Down With podcast with Diana Spencer, Charles Powell, CEO of Aurora Microplates, discusses how microplate technology has evolved to keep up with changing trends in drug discovery and why this ubiquitous, almost invisible, tool can have a huge impact on the reliability of scientific investigations. DS:… Read More

#Exclusive Content

384-well microplate
#Assays #Aurora Microplates #Drug development #Drug discovery #Lab technology #Podcast #Preclinical development

Podcast: How the tools you use impact precision in the lab

The latest sponsored DDW Sitting Down With podcast is now available. It features Charles Powell, CEO of Aurora Microplates, discussing how the Aurora microplate has evolved to keep up with changing trends within research and development. The microplate is a seemingly simple tool, yet it has… Read More

#News

384-well microplate
#Assays #Aurora Microplates #Drug development #Drug discovery #Lab technology #Preclinical development

How the tools you use impact consistency and precision in the lab

The latest sponsored DDW Sitting Down With podcast features Charles Powell, CEO of Aurora Microplates, discussing how the microplate has evolved to keep up with changing trends within research and development. The microplate is a seemingly simple tool, yet it has a crucial role to play… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Events #Lab technology #SLAS2024

Speakers announced for SLAS2024 Ignite Theater: Register now

The line-up of speakers is now confirmed for the SLAS2024 Ignite Theater: ‘Innovation & technology: from lab to patient’, curated by DDW and sponsored by Integra Biosciences and Hamamatsu Corporation. The event will take place on 5 and 6 February 2024 at SLAS in Boston, and will present… Read More

#News

#Artificial intelligence (AI) #Cell and gene therapy #Drug discovery #Generative AI

Can vertical AI advance cell and gene therapies? 

Andrew Busey, Co-Founder, Form Bio, discusses why vertical AI is set to reshape the cell and gene therapy sector. The once-fictional artificial intelligence (AI) depicted in literature and movies has transitioned into a tangible and easily accessible tool in our modern world. General AI tools such as ChatGPT have… Read More

#Exclusive Content

#Drug development #Drug discovery #Guide #Human disease models #Mouse models #Pharmokinetics

HuPK: A Humanised Platform for therapeutic antibody PK evaluation

Download the guide to learn more about:   How JAX’s HuPK™ Humanised FcRn Platform offers a validated and cost-effective solution for assessing the in vivo  preclinical pharmacokinetics and stability of Fc-based biologics and therapeutics carried by albumin.    JAX’s… Read More

#Intelligence #Resources

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

New DDW Highlights podcast: 4 December 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  The key drug discovery news this week focuses on experimental approaches to… Read More

#News

#Alzheimer's #Cancer research #Cell therapy #CRISPR #Drug discovery #Parkinson's #Plant-based #Stem cells

This week in drug discovery (27 Nov – 1 Dec) 

News round-up for 27 November – 1 December by DDW Digital Content Editor Diana Spencer. The key drug discovery news this week focuses on experimental approaches to the treatment of some of the most challenging diseases, including a mathematical model that can simulate Alzheimer’s progression and… Read More

#News